Monday, 17 August 2026
PERSPECTA
News from every angle
All
Stream
World
Politics
Business
Technology
Finance
Science
Health
Culture
Opinion
Environment
← Back to headlines
ImmunityBio Inc. (IBRX) Announces Approval for ANKTIVA® in Macau SAR, China
25 Mar, 14:52 — 25 Mar, 14:52
Post
Share
Copy link
Embed
Sources
Sort: Relevance
Sort: Latest
Sort: Bias (L→R)
Sort: Bias (R→L)
Sort: Factuality
left
center
right
Showing 1 of 1 sources
Yahoo
Mostly Factual
145d ago
ImmunityBio Inc. (IBRX) Announces Approval for ANKTIVA® in Macau SAR, China
Read full article →
Something wrong with this story? Report an issue
Related Stories
Bulgaria Returns 11.6 Tons of Peppers to North Macedonia Due to Pesticides
35m ago
Goldman Sachs to Acquire ETF Provider Neos in $2.3 Billion Deal
41m ago
L3Harris CEO Chris Kubasik Ousted Over Unspecified Conduct
43m ago
KBR Secures $60 Million NATO Contract for Missile Defense System
53m ago
Monday, 17 August 2026
Explore
Log in
Sign up
en
PERSPECTA
News from every angle
